MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
REPL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Replimune Group (REPL) Ownership - Who owns Replimune Group?

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
479
Web
https://www.replimune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
741.5M
P/E Ratio
N/A
Total Cash
269.14M
Projected Growth
N/A
Total Debt
76.35M
Revenue
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
3.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
REPL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for REPL
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
479
Web
https://www.replimune.com